rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-9-18
|
pubmed:abstractText |
There is minimal evidence that HMG-CoA reductase inhibitors (statins) are beneficial in patients with chronic heart failure (CHF). Treatment with statins may lead to a lower mortality in CHF, independent of cholesterol levels, CHF etiology and clinical status.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1874-1754
|
pubmed:author |
pubmed-author:AnkerStefan DSD,
pubmed-author:BanasiakWaldemarW,
pubmed-author:CicoiraMariantoniettaM,
pubmed-author:ClarkAndrew LAL,
pubmed-author:CoatsAndrew J SAJ,
pubmed-author:DavosConstantinos HCH,
pubmed-author:HaassMarkusM,
pubmed-author:PittBertramB,
pubmed-author:PonikowskiPiotrP,
pubmed-author:Poole-WilsonPhilip APA,
pubmed-author:SengesJochenJ,
pubmed-author:WinklerRalfR,
pubmed-author:ZardiniPieroP,
pubmed-author:ZugckChristianC
|
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
234-42
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16846656-Aged,
pubmed-meshheading:16846656-Body Mass Index,
pubmed-meshheading:16846656-Captopril,
pubmed-meshheading:16846656-Cardiovascular Agents,
pubmed-meshheading:16846656-Female,
pubmed-meshheading:16846656-Heart Failure,
pubmed-meshheading:16846656-Humans,
pubmed-meshheading:16846656-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:16846656-Losartan,
pubmed-meshheading:16846656-Male,
pubmed-meshheading:16846656-Middle Aged,
pubmed-meshheading:16846656-Multivariate Analysis,
pubmed-meshheading:16846656-Oxygen Consumption,
pubmed-meshheading:16846656-Proportional Hazards Models,
pubmed-meshheading:16846656-Randomized Controlled Trials as Topic,
pubmed-meshheading:16846656-Retrospective Studies,
pubmed-meshheading:16846656-Survival Analysis
|
pubmed:year |
2006
|
pubmed:articleTitle |
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
|
pubmed:affiliation |
Applied Cachexia Research, Department of Cardiology, Charité Campus Virchow-Klinikum, Berlin, Germany. s.anker@imperial.ac.uk
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|